Q2FY27 business update: revenue grew about 15% Y-o-Y; EBITDA margins improve both Y-o-Y and Q-o-Q
Q2FY27 business update (consolidated): revenue up ~15% Y-o-Y, led by double digit patient and test volume growth, plus improved realizations and product mix.
- Revenue Growth
- revenue up ~15% Y-o-Y
- Volume Growth
- double digit patient and test volume growth
- Margin Trend
- EBITDA margins improved meaningfully Y-o-Y and Q-o-Q
- Fastest-Growing Segments
- TruHealth Wellness & Specialty
- Margin Drivers
- operating leverage and efficiency gains
What the company shared
Metropolis Healthcare has given a business update for the quarter ended September 30, 2026 (Q2FY27), covering operating performance and demand trends during the quarter. The update is on a consolidated basis and comes ahead of the formal Q2FY27 results.
The three highlights it lists
- Revenue grew by approximately 15% on a Y-o-Y basis, primarily driven by double digit patient and test volume growth, supported by improved realizations and a change in product mix.
- TruHealth Wellness and Specialty emerged as the fastest-growing segments during the quarter.
- EBITDA margins have improved meaningfully on a Y-o-Y as well as Q-o-Q basis, driven by operating leverage and efficiency gains.
How to read a business update
A quarterly business update like this is an early snapshot of how the business performed operationally. It focuses on direction and trends — the revenue growth rate, the nature of volume growth, margin movement and which segments are growing fastest.
What the trends point to
- Growth is described as volume-led, with double digit patient and test volume growth, and improved realizations and product mix adding support.
- Margins are stated to have improved on both a Y-o-Y and a Q-o-Q basis, which the company attributes to operating leverage and efficiency gains.
- Within the portfolio, TruHealth Wellness and Specialty are called out as the fastest-growing segments for the quarter.
What follows
The update states that a detailed information update will follow once the Board of Directors approves the financial results for Q2FY27, and that the financial results of Q2FY27 are subject to review by Auditors.
Also from Metropolis Healthcare
Metropolis Q2 business update showed 15% revenue growth driven by patient and test volume growth, with improved EBIT margins
6 Oct 2026
Metropolis Healthcare's business update showed ~15% revenue growth driven by volume growth and improved realization
6 Oct 2026
Metropolis Healthcare's revenue grew 15% with better margins
6 Oct 2026
More numbers
- Revenue growth Y-o-Yapproximately 15%
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.